Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: A single-center, multiple-dose, open-label study
- 31 October 2005
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (10) , 1596-1606
- https://doi.org/10.1016/j.clinthera.2005.10.006
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's diseaseJournal of Alzheimer's Disease, 2005
- Insulin signaling, diabetes mellitus and risk of Alzheimer diseaseJournal of Alzheimer's Disease, 2005
- Cardiovascular risk factors and Alzheimer’s diseaseCurrent Atherosclerosis Reports, 2004
- Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetesExpert Opinion on Pharmacotherapy, 2003
- Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and AgingAmerican Journal of Epidemiology, 2002
- Diabetes mellitus and the risk of dementiaNeurology, 1999
- Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterizationNeuropharmacology, 1999
- Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994Diabetes Care, 1998
- Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics SocietyPublished by American Medical Association (AMA) ,1997
- MetforminDrugs, 1995